Skip to main content

Published locations for Is Hypomagnesemia a Marker of Efficacy of Cetuximab in Locoregionally Advanced and Metastatic Head and Neck Cancer?

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Is Hypomagnesemia a Marker of Efficacy of Cetuximab in Locoregionally Advanced and Metastatic Head and Neck Cancer?

User login

  • Reset your password
  • /content/hypomagnesemia-marker-efficacy-cetuximab-locoregionally-advanced-and-metastatic-head-and
  • /fedprac/article/146365/head-neck-cancers/hypomagnesemia-marker-efficacy-cetuximab-locoregionally
  • /fedprac/avaho/article/146365/head-neck-cancers/hypomagnesemia-marker-efficacy-cetuximab